Company Filing History:
Years Active: 2019
Title: Innovator Chung Hao Chang: Advancements in Vaccines
Introduction: Chung Hao Chang, a notable inventor based in Taipei, Taiwan, has made significant strides in the field of immunology. With a focus on enhancing vaccine efficacy, Chang has contributed to medical advancements through innovative inventions.
Latest Patents: Chang holds a patent for his invention titled "Vaccines with Higher Carbohydrate Antigen Density and Novel Saponin Adjuvant." This patent presents a groundbreaking approach to vaccine development by utilizing carbohydrate antigens conjugated to diphtheria toxin as a carrier protein. The invention boasts a higher ratio of carbohydrate antigen molecules to carrier protein molecules, exceeding 5:1, which is believed to enhance immune response. Additionally, it introduces a novel saponin adjuvant and methods aimed at inhibiting cancer cells through effective vaccine administration.
Career Highlights: Currently, Chung Hao Chang is affiliated with Obi Pharma Inc., a company renowned for its innovative approaches in pharmaceuticals. Within this role, he has been instrumental in driving research and development forward, focusing on vaccines that exhibit improved performance against various diseases.
Collaborations: Chang collaborates with prominent colleagues, including Wei Lee and Nan-Hsuan Wang, who contribute their expertise in supporting his innovative endeavors. Together, they strive to advance research in immunology and develop cutting-edge solutions.
Conclusion: Through his inventive work and collaborative spirit, Chung Hao Chang is positioned as a key figure in vaccine innovation. His contributions not only highlight his commitment to advancing medical science but also enhance the understanding of immune responses critical for tackling diseases, including cancer.